PAPO; Niv

Patent Applications and Registrations

Patent applications and USPTO patent grants for PAPO; Niv.The latest application filed is for "a single-domain antibody for targeting prostate specific membrane antigen (psma)".

Company Profile

2.6.12

PAPO; Niv - Raanana IL
Papo; Niv - Ra'anana IL
Papo; Niv - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
A Single-domain Antibody For Targeting Prostate Specific Membrane Antigen (psma) App 20220306764 - PAPO; Niv ; et al.	2022-09-29
Compositions And Methods For Treatment Of Bone Associated Diseases App 20210403514 - PAPO; Niv ; et al.	2021-12-30
Compositions and methods for treatment of bone associated diseases Grant 11,098,091 - Papo , et al. August 24, 2	2021-08-24
Compositions And Methods For Treatment Of Bone Associated Diseases App 20190248845 - PAPO; Niv ; et al.	2019-08-15
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin App 20190048051 - Cochran; Jennifer R. ; et al.	2019-02-14
VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAIN App 20180362616 - PAPO; Niv ; et al.	2018-12-20
Polypeptides targeting vascular endothelial growth factor receptor-2 and .alpha.v.beta.3 integrin Grant 9,505,822 - Cochran , et al. November 29, 2	2016-11-29
Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin Grant 9,441,026 - Cochran , et al. September 13, 2	2016-09-13
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin App 20160039895 - Cochran; Jennifer R. ; et al.	2016-02-11
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 And Alpha V Beta 3 Integrin App 20160039896 - Cochran; Jennifer R. ; et al.	2016-02-11
Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin Grant 9,234,021 - Cochran , et al. January 12, 2	2016-01-12
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin App 20150037888 - Cochran; Jennifer R. ; et al.	2015-02-05
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin App 20150037889 - Cochran; Jennifer R. ; et al.	2015-02-05
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin App 20150005235 - Cochran; Jennifer R. ; et al.	2015-01-01
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin App 20140356286 - Cochran; Jennifer R. ; et al.	2014-12-04
Polypeptides targeting vascular endothelial growth factor receptor-2 and .alpha.v.beta.3 integrin Grant 8,741,839 - Cochran , et al. June 3, 2	2014-06-03
Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin App 20120020889 - Cochran; Jennifer R. ; et al.	2012-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.